Roth, who is also a professor in the School of Pharmacy’s medicinal chemistry and natural products division, is one of 11 scientists to receive a “Distinguished Investigator” award from NARSAD (previously known as the National Alliance for Research on Schizophrenia and Depression), a leading charity dedicated to funding research on psychiatric disorders.
The award includes a one-year grant of $100,000 to advance Roth’s research on schizophrenia.
NARSAD created the Distinguished Investigator Award to support highly significant research by established scientists – full professors or their equivalent – who are on the cusp of a breakthrough, or who are poised to test an innovative new idea that has the potential to make a significant advance in a given area of research.
Roth, whose laboratory houses the National Institute of Mental Health Psychoactive Drug Screening Program, is using genetically engineered mice to shed new light on the neuronal pathways of schizophrenia. His work will help provide information for developing screening campaigns to identify new drugs for schizophrenia and related disorders.